Angina Pectoris Clinical Trials

26 recruitingLast updated: June 19, 2026

There are 26 actively recruiting angina pectoris clinical trials across 18 countries. Studies span Not Applicable, Phase 4, Phase 2, Phase 3. Top locations include Lucerne, Canton of Lucerne, Switzerland, London, United Kingdom, Copenhagen, Denmark. Updated daily from ClinicalTrials.gov.


Angina Pectoris Trials at a Glance

26 actively recruiting trials for angina pectoris are listed on ClinicalTrialsFinder across 6 cities in 18 countries. The largest study group is Not Applicable with 12 trials, with the heaviest enrollment activity in Lucerne, London, and Copenhagen. Lead sponsors running angina pectoris studies include Biotronik AG, Luzerner Kantonsspital, and Clinical Center Niš.

Browse angina pectoris trials by phase

Treatments under study

About Angina Pectoris Clinical Trials

Looking for clinical trials for Angina Pectoris? There are currently 14 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Angina Pectoris trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Angina Pectoris clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 26 trials

Recruiting
Not Applicable

Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold (RMS) System in Subjects With Coronary Artery Lesions

Arterial Occlusive DiseasesPainCardiovascular Diseases+12 more
Teleflex1,859 enrolled1 locationNCT07258290
Recruiting
Not Applicable

Self Expanding Coronary Sinus Reducer for Treatment of Symptomatic Coronary Microvascular Dysfunction (CMD)

Cardiovascular DiseasesMyocardial IschemiaHeart Diseases+3 more
VahatiCor, Inc.30 enrolled2 locationsNCT07449325
Recruiting

Clinical Characteristics, Frailty, and Prognostic Predictors in Patients Aged 75 and Older With Acute Coronary Syndrome

Unstable Angina PectorisST Elevation (STEMI) Myocardial InfarctionNon ST Elevation Myocardial Infarction (NSTEMI)
Clinical Center Niš550 enrolled1 locationNCT07366684
Recruiting
Not Applicable

Speed-up the Diagnosis and Evaluation of anoMalous Coronary ARTery From the Aorta

Myocardial IschemiaSudden Cardiac DeathAAOCA+7 more
IRCCS Policlinico S. Donato38 enrolled1 locationNCT06705751
Recruiting
Not Applicable

Intracoronary Cryotherapy Effect on Stabilization of Vulnerable Plaque in Patients With Stable Angina or ACS - A Traditional Feasibility Study

plaqueCryotherapy EffectCryotherapy+4 more
Cryotherapeutics SA30 enrolled3 locationsNCT06939374
Recruiting
Not Applicable

Aerobic Exercise-induced Effect on Endothelial Function in Patients With Ischaemic Heart Disease

Cardiorespiratory FitnessAcute Myocardial InfarctionAngina, Stable+3 more
Instituto de Investigación Sanitaria y Biomédica de Alicante132 enrolled2 locationsNCT06788275
Recruiting
Phase 2

Assessing the Safety and Effectiveness of Intracoronary Stem Cells in Patients With Refractory Angina

Refractory AnginaRefractory Angina Pectoris
Barts & The London NHS Trust110 enrolled1 locationNCT05711849
Recruiting
Not Applicable

Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold System in the Treatment of Subjects With Long de Novo Lesions

Myocardial IschemiaCoronary Artery DiseaseIschemic Heart Disease+3 more
Biotronik AG100 enrolled8 locationsNCT07091682
Recruiting
Not Applicable

Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold System

Acute Coronary SyndromeMyocardial IschemiaCoronary Artery Disease+3 more
Biotronik AG1,859 enrolled1 locationNCT05540223
Recruiting

TTE Improves Clinical Management of Stable Chest Pain

Stable Angina PectorisCoronary Artery DiseaseMajor Adverse Cardiac Events+2 more
Tianjin Chest Hospital50,000 enrolled1 locationNCT07063147
Recruiting
Phase 4

Implantable Cardioverter Defibrillator Versus Optimal Medical Therapy In Patients With Variant Angina Manifesting as Aborted Sudden Cardiac Death

Sudden Cardiac DeathAngina Pectoris, Variant
Kee-joon Choi140 enrolled25 locationsNCT02845531
Recruiting
Phase 4

The Effects of Tirzepatide in People With Overweight/Obesity and Coronary Artery Disease

chronic coronary artery diseaseStable Angina PectorisCoronary Artery Disease+3 more
Tina Vilsbøll124 enrolled3 locationsNCT06606821
Recruiting

International Survey of Acute Coronary Syndromes

Coronary DiseaseAcute Coronary SyndromeMyocardial Infarction+1 more
University of Bologna36,000 enrolled1 locationNCT01218776
Recruiting
Phase 3

Outcome Research to Confirm the Anti-anginal Effect of T89 in Patients With Stable Angina

Chronic Stable Angina Pectoris
Tasly Pharmaceuticals, Inc.765 enrolled1 locationNCT03789552
Recruiting
Not Applicable

Coronary Sinus Reducer Implantation in Patients With Ischaemia and Non-obstructed Coronary Arteries and Coronary Microvascular Dysfunction.

Coronary DiseaseAngina PectorisMicrovascular Coronary Artery Disease+2 more
Imperial College London54 enrolled1 locationNCT05492110
Recruiting
Phase 4

Efficacy and Safety of Aspirin in Patients With Chronic Coronary Syndromes Without Revascularization

Stable Angina PectorisCoronary Artery DiseaseIschemic Heart Disease
Takeshi Morimoto2,890 enrolled1 locationNCT05347069
Recruiting
Not Applicable

Coronary Computed Tomography Versus Invasive Angiography for Non-ST Elevation Acute Coronary Syndrome

Coronary DiseaseRandomized Controlled TrialDiagnostic Imaging+9 more
Rigshospitalet, Denmark2,300 enrolled6 locationsNCT06101862
Recruiting
Phase 2Phase 3

Efficacy of Targeted Medical Therapy in Angina and Nonobstructive Coronary Arteries

Angina PectorisMicrovascular AnginaVasospastic Angina+1 more
Stanford University150 enrolled1 locationNCT06424834
Recruiting

SIROOP Registry - A Prospective Registry Study to Evaluate the Outcomes of Coronary Artery Disease Patients Treated With SIROlimus Or Paclitaxel Eluting Balloon Catheters

Coronary RestenosisCoronary DiseaseCoronary Artery Disease+7 more
Luzerner Kantonsspital2,000 enrolled1 locationNCT04988685
Recruiting

COMPLEX Registry - a Prospective COhort Study to Describe the Management and Outcomes of Patients Presenting with CompLEX and Calcified Coronary Artery Disease

Coronary RestenosisCoronary DiseaseCoronary Artery Disease+7 more
Luzerner Kantonsspital5,000 enrolled1 locationNCT06075602